# SITAGLIPTIN AND METFORMIN HYDROCHLORIDE
> **ANDA216644** · Abbreviated New Drug Application (Generic) · Sponsor: ANNORA PHARMA PRIVATE LIMITED · Approved 2026-09-14
## Drug
- **FDA Application Number:** ANDA216644
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SITAGLIPTIN AND METFORMIN HYDROCHLORIDE
- **Generic name:** Sitagliptin, Metformin Hydrochloride
- **Active ingredients:** SITAGLIPTIN, METFORMIN HYDROCHLORIDE
- **Dosage form:** TABLET
- **Route:** —
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** ANNORA PHARMA PRIVATE LIMITED
- **First approval:** 2026-09-14
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216644)
---
*MORVS · CC0 1.0*